Keyphrases
Asthma
100%
Severe Asthma
82%
Finland
66%
Oral Corticosteroids
33%
Forced Expiratory Volume in 1 Second (FEV1)
32%
Adult Asthma
29%
Respiratory Symptoms
25%
Sweden
24%
Chronic Obstructive Pulmonary Disease
24%
Inhaled Corticosteroids
24%
Comorbidity
23%
Lung Function
23%
Celiac Disease
21%
Asthma Research
20%
Interstitial Lung Disease
20%
Cross-country Skiers
19%
Research Cohort
19%
Allergy
17%
Asthma Control
17%
Exacerbation Rate
16%
Asthma Diagnosis
16%
Fractional Exhaled Nitric Oxide (FeNO)
16%
Skiers
16%
Asthmatic
14%
Asthma Symptoms
14%
Hospitalization
14%
Finnish Population
14%
Type 2 Inflammation
14%
Population-based
14%
Asthma Hospitalization
13%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
13%
Asthma Patients
13%
Dermatitis Herpetiformis
13%
Autoantibodies
13%
Workplace
13%
Nordic Countries
13%
Moisture Damage
13%
Blood Eosinophil Count
13%
Peak Expiratory Flow
13%
Bronchoconstriction
13%
T2-low
13%
Idiopathic Pulmonary Fibrosis
13%
Biologic Initiation
13%
Foundry Workers
13%
Multiple Chemical Sensitivity
12%
Airway Obstruction
11%
Cough
11%
Airway
11%
Tampere
10%
Anti-IL-5
10%
Health-related Quality of Life
10%
Dyspnea
10%
Healthcare Resource Utilization
10%
Anti-IgE
9%
Biological Treatment
9%
Biologic Therapy
9%
Allergy Diagnosis
9%
Treatment Response
9%
Standardized Incidence Ratio
8%
Diabetes
8%
Pathophysiology
8%
Associated Symptoms
8%
Risk Factors
8%
Biologic Response
8%
Acute Respiratory Infection
8%
Chronic Cough
8%
Asthma Onset
8%
Confidence Interval
8%
Skin Diseases
8%
Multidisciplinary Approach
8%
Odds Ratio
8%
Severe Uncontrolled Asthma
8%
Obstructive Airway Disease
7%
Disease Burden
7%
Wound Registry
7%
Pulmonary Disease
7%
Chronic Rhinosinusitis
7%
Asthma Outcomes
7%
Pneumonia
7%
Airway Disease
7%
Older Adults
7%
High Dose
7%
Dust Exposure
7%
Plasma Cells
7%
Atopic Asthma
7%
Low Prevalence
6%
Orthopedic Infection
6%
Prolonged Cough
6%
Corticosteroid Exposure
6%
Corticosteroid Use
6%
Dry Powder Inhaler
6%
Environmental Determinants
6%
Biomarker Stability
6%
Transglutaminase 2
6%
Quality Registry
6%
Home Mechanical Ventilation
6%
Long-term Cohort Study
6%
Sinus Imaging
6%
Tumor
6%
Aspirin Hypersensitivity
6%
Medicine and Dentistry
Asthma
83%
Severe Asthma
57%
Biological Product
40%
Chronic Rhinosinusitis
22%
Diseases
21%
Coughing
21%
Interstitial Lung Disease
20%
Cohort Analysis
20%
Nasal Polyp
18%
Chronic Obstructive Pulmonary Disease
18%
Comorbidity
18%
Lung
16%
Prevalence
15%
Quality of Life
14%
Coeliac Disease
13%
Wound
13%
Idiopathic Pulmonary Fibrosis
13%
Symptomatic Treatment
13%
Forced Expiratory Volume
12%
Dyspnea
11%
Immunoglobulin E
11%
Standardized Incidence Ratio
10%
Pediatrics
9%
Biological Therapy
9%
Biological Marker
9%
Treatment Response
9%
Basal-Cell Carcinoma
9%
Chronic Cough
8%
Infection
8%
Psoriasis
7%
Respiratory Disease
7%
Pathophysiology
7%
Clinical Finding
7%
Silo-Filler's Disease
7%
Diagnosis
7%
Disease Burden
7%
Odds Ratio
7%
Patient Referral
6%
Dermatitis Herpetiformis
6%
Retrospective Cohort Study
6%
Low Drug Dose
6%
Phototherapy
6%
Skin Cancer
6%
Neoplasm
6%
Kidney Graft
6%
Noninvasive Ventilation
6%
Observational Study
6%
Vascular Disease
6%
Skin Carcinoma
6%
Cancer Risk
6%
Venous Ulcer
6%
Volume CT
6%
Paranasal Sinus
6%
Pyoderma gangrenosum
6%
Cigarette Smoking
6%
Skin Transplantation
6%
Ulcer
6%
Ichthyosis
6%
Autoinjector
6%
Epinephrine
6%
Genetic Screening
6%
Bronchoconstriction
6%
Peak Expiratory Flow
6%
Orthopedic Implant
6%
Bloodstream Infection
6%
Case-Control Study
6%
Retrospective Study
6%
Lung Cancer
6%
Hantavirus
6%
Aminolevulinic Acid Methyl Ester
6%
Aminolevulinic Acid Hexyl Ester
6%
Aminolevulinic Acid
6%
Photochemotherapy
6%
Functional Endoscopic Sinus Surgery
6%
Health Care Cost
5%
Randomized Controlled Trial
5%
Population
5%
Multiple Chemical Sensitivity
5%